SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Lou Gehrig

PatientLou Gehrig
Date of birth1990-06-19
IdentifiersMRN HR-ET018-SYN; SSN (made up) 000-18-6620
Document date2026-10-19
AuthorGavin Hollister, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Five months after diagnosis: breathing tests and ventilation planning, nutrition and gastrostomy, speech, and his new desk work. [S]

History of Present Illness

Mr. Gehrig returns five months after the diagnosis, on the day of his ALS clinic visit. He started his desk role in city public service two weeks ago with the accommodations in place and works four days a week. He sleeps flat, with no breathlessness, morning headaches or daytime sleepiness, but tires after climbing the stairs. His speech slurs more by evening; he coughs once or twice with thin drinks. His weight is down a little further despite extra calories. The power wheelchair has been approved and is due next month. His hepatitis B and C screening tests from the preventive visit were negative, so he is not immune to hepatitis B and continues the vaccine series today. [S]

ElementDetail
WorkDesk role in public service for two weeks; four days a week; accommodations in place
BreathingNo orthopnea, morning headaches or daytime sleepiness; tired after stairs
Speech and swallowingMore slurring by evening; occasional cough with thin drinks
WeightDown a little further
ResultsHepatitis B and C screening negative

Review of Systems

SystemResultFinding
RespiratoryPositiveTired after stairs; no orthopnea or morning headaches
Ears, nose, mouth, and throatPositiveSlurred speech by evening; occasional cough with thin drinks; no drooling
ConstitutionalPositiveWeight 86.6 kg; no fever
NeurologicalPositiveWeaker hands and left leg; no numbness
PsychiatricNegativeMood steadier since starting work; PHQ-9 6

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Riluzole 50 mg oral tablet, one tablet by mouth twice daily, an hour before or two hours after mealsOne tablet by mouth every 12 hours on an empty stomachOral route2026-05-18activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food as needed for ankle pain, for up to 5 daysOne tablet by mouth every 8 hours with food as needed, up to 5 daysOral route2026-07-20 to 2026-07-25completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-19Body height183cmS
2026-10-19Body weight86.6kgS
2026-10-19Body mass index (BMI) [Ratio]25.9kg/m2S
2026-10-19Systolic blood pressure118mm[Hg]S
2026-10-19Diastolic blood pressure74mm[Hg]S
2026-10-19Heart rate76/minS
2026-10-19Respiratory rate16/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L7-55 U/LNormalS
2026-10-19Forced vital capacity [Volume] Respiratory system3.69L>=4.1 LLowS
2026-10-19FVC measured/predicted72%80% of predicted or more is normal; noninvasive ventilation is considered below 50%LowS
2026-10-19Total score [ALSFRS-R]36{score}S
2026-10-19Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 118/74, pulse 76, oxygen saturation 97%; weight 86.6 kg
NeurologicalModerate hand weakness (grip 3+/5); left ankle dorsiflexion 3/5; mild to moderate dysarthria; tongue fasciculations; brisk jaw jerk
RespiratoryClear; slight paradoxical abdominal movement when lying flat

Problems

ProblemClinical statusVerificationCodeProvenance
Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation bookedresolvedconfirmed M62.81S — Synthetic presenting problem anchored to his documented decline in 1938 and 1939; superseded by the diagnosis.
Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosisactiveconfirmed G12.21S — Synthetic modern diagnosis; the documented 1939 diagnosis is the anchor. EMG findings, scores and timing are synthetic.
Sprain of the left lateral ankle ligaments after tripping on a curb with left foot drop, while not wearing his ankle-foot orthosis: swelling and tenderness over the anterior talofibular ligament, able to bear weight, no bony tenderness by the Ottawa ankle rules; resolvedresolvedconfirmed S93.402AS — Synthetic injury; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyALSFRS-REvery 2 to 3 months in the multidisciplinary ALS clinicCompleted today36 of 48
ImagingSeated forced vital capacityEvery 2 to 3 months in the multidisciplinary ALS clinicCompleted today3.69 L, 72% of predicted seated; 63% supine
ExaminationMaximal inspiratory pressure; supine capacity and overnight oximetry when values fall or symptoms appearEvery 2 to 3 months in the multidisciplinary ALS clinicOrderedMaximal inspiratory pressure -62 cmH2O; supine FVC 63%; overnight oximetry ordered
ExaminationNoninvasive ventilation criteria (FVC below 50%, maximal inspiratory pressure weaker than -60 cmH2O, nocturnal desaturation, orthopnea)Every 2 to 3 months in the multidisciplinary ALS clinicDueNot yet met; close on maximal inspiratory pressure; fitting planned as soon as oximetry or tests meet a criterion
ExaminationWeight and BMI (gastrostomy discussion if weight falls 5 to 10% or swallowing is unsafe; place while FVC is above 50%)Every visitCompleted today86.6 kg, 2.9% below diagnosis; gastrostomy discussed
ExaminationSpeech and swallowing assessmentEvery 2 to 3 months in the multidisciplinary ALS clinicOrderedMild to moderate dysarthria; cough with thin liquids; swallowing study ordered
SurveyCognitive and behavioral screeningAt diagnosis and periodicallyCompleted todayBrief screen repeated in clinic; normal
SurveyDepression (PHQ-9)Every visitCompleted todayPHQ-9 6
ExaminationSymptoms: cramps, spasticity, saliva, emotional lability, painEvery visitCompleted todayNo drooling or emotional lability; cramps controlled
ExaminationMobility, falls, orthoses and equipmentEvery visitCompleted todayOrthosis and cane; power wheelchair approved, due next month; no falls
LaboratoryALT on riluzoleMonthly for 3 months, then every 3 monthsCompleted todayALT 33 U/L
ReferralMultidisciplinary ALS clinicEvery 2 to 3 months in the multidisciplinary ALS clinicCompleted todaySeen today
Self-managementWork, disability benefits and social workFrom diagnosisCompleted todayWorking four days a week with accommodations
Self-managementAdvance care planningEarly, then at each changeCompleted todayRecorded at the preventive visit; reviewed today with the ventilation and feeding decisions ahead
Self-managementVaccination reviewYearlyCompleted todayInfluenza and COVID-19 at the preventive visit; second hepatitis B dose today

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), second of two doses [S]

Guideline basis: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function (1999); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: Overnight oximetry and swallowing study within two weeks; respiratory therapist to fit noninvasive ventilation when a criterion is met. Decision on gastrostomy within a month. ALS clinic in about two months. [S]